Products
B2B Zone
5th Genome Editing Therapeutics 2024
5th Genome Editing Therapeutics 2024
Conferences

5th Genome Editing Therapeutics 2024

By

Hanson Wade

2 Followers
03 Dec 2024 - 05 Dec 2024
Free Registration

Event Details

5th Genome Editing Therapeutics 2024

The 5th Genome Editing Therapeutics Summit (formerly CRISPR 2.0) is the industry's foremost meeting for spearheading the development, application, and delivery of novel gene editing technologies in the therapeutic setting. Data-driven talks, expert panel discussions, and interactive group discussions will cover the therapeutic application and drug development challenges of both:

1. More established technologies, and their associated translational, nonclinical, clinical, and strategic challenges: including novel nucleases, base, prime, and multiplex editing techniques

2. Ground-breaking precision tools enabling small and large alterations to the genome, including epigenome editing, recombinase and transposon-based technologies, and novel delivery vehicles

Across three days, industry and academic leaders will share the latest data on the cutting-edge therapies they are progressing through development, tying in the strategies they are deploying to ensure their safety, precision, and regulatory compliance.

This is the industry's only gene editing meeting that prioritizes drug development first, with a particular focus on robust safety packages, off-target detection, and nomination strategies; facilitating successful IND filings. Leverage actionable insights to improve the precision and safety of your technology, unlock the ability to perform small and large targeted edits, and outline a streamlined path to clinic for your lead program.

Join us to be a part of the gene editing revolution!

URLs:
Tickets: https://go.evvnt.com/2614921-0?pid=10018
Brochure: https://go.evvnt.com/2614921-2?pid=10018

Prices:
Drug Developer - All Access Pass (Conference + Workshop Day): USD 4197.00,
Drug Developer - Conference Only: USD 2999.00,
Academic - All Access Pass (Conference + Workshop Day): USD 3597.00,
Academic - Conference Only: USD 2599.00,
Solution Provider - All Access Pass (Conference + Workshop Day): USD 5097.00,
Solution Provider - Conference Only: USD 3699.00

Speakers: Andrew Anzalone, Director, Head of Prime Editing Platform, Prime Medicine, Ankit Gupta, Senior Director, Head of Gene Editing, Affini-T Therapeutics, Apiwat Wangweerawong, Director, Delivery Chemistry, Tessera Therapeutics, Barrett Nuttall, Director, AstraZeneca, Brett Staahl, Co-Founder and Vice President, External Innovation, Scribe Therapeutics, Britta Jones, Senior Scientise, Tune Therapeutics, Bryant Chica, Scientist II, Analytical Chemistry and Structural Biology, Editas Medicine, Carlo Zambonelli, Independent LNP Expert, Christina Jordan, Senior Director, IP, Tune Therapeutics, Dave Carter, Senior Director, Head of Research, Evox Therapeutics, Gabor Veres, Senior Vice President, Translational Research, Mammoth Biosciences, Jeffrey Cehelsky, Vice President - Development Operations, Intellia Therapeutics, Jeffrey Marshall, Analytical Director, mRNA and gRNA Platforms, Beam Therapeutics, Jim Wang, Vice President Regulatory Affairs, Genetic Medicine, Regeneron Pharmaceuticals, John Finn, Chief Scientific Officer, Tome Biosciences, John Murphy, Chief Scientific Officer, Arbor Biotechnologies, Jordanna Mora, Senior Director, Patient Advocacy and Centricity, Beam Therapeutics, Joseph Nabhan, Chief Scientific Officer, Vesigen Therapeutics, Kiran Musunuru, Professor of Cardiovascular Medicine and Genetics, Perelman School of Medicine, University of Pennsylvania, Laura Serwer, Senior Director, Head of Pharmacology and Toxicology, CRISPR Therapeutics, Luca Biasco, Vice President, Translational Sciences, Nvelop Therapeutics, Marco Weinberg, Senior Vice President, Head of Research, ReCode Therapeutics, Inc, Narin Ahmed, Vice President, Regulatory Science, Tessera Therapeutics, Omid Harandi, Chief Scientific Officer, Komo Biosciences, Priya Chockalingam, Vice President, Head of Clinical Bioanalytics and Translational Sciences, Beam Therapeutics, Ryan Leenay, Associate Vice President, Eli Lilly and Co., Ryo Takeuchi, Senior Director, Genome Editing, Excision BioTherapeutics, Safi Shahda, Senior Medical Director, Intellia Therapeutics, Sam Sternberg, Assistant Professor, Department of Biochemistry and Molecular Biophysics, Columbia University, Shane Wright, Associate Scientist II, Chroma Medicine, Sheryl Bowley, Director, HSC Therapies, Editas Medicine, Tobias Brambrink, Vice President, Legal and Intellectual Property, Chroma Medicine, Vivian Choi, Head of Liver, Metabolic, Lung, Eye and Ear Disease Unit, Prime Medicine

Entry Fees

Free Registration

Categories

Event Frequency

One Time

Event Timings

(GMT-5:00) Central Time (US and Canada)
09:00 AM - 03:10 PM (Dec 03, Dec 04, Dec 05) (Public)

Speakers

Andrew Anzalone
Andrew Anzalone
Director, Head of Prime Editing Platform, Prime Medicine
Ankit Gupta
Ankit Gupta
Senior Director, Head of Gene Editing, Affini-T Therapeutics
Apiwat Wangweerawong
Apiwat Wangweerawong
Director, Delivery Chemistry, Tessera Therapeutics
Barrett Nuttall
Barrett Nuttall
Director, AstraZeneca

Comments on 5th Genome Editing Therapeutics 2024

You must to write a comment.

Peoples Interested in Visit

0 Peoples Interested to Visit

Event Location

Hilton Boston Back Bay
40, Dalton Street, Back Bay, Boston ,
Boston 02115, Massachusetts, United States
Official Link :

More Events By Organizer

2nd Covalent Drug Discovery and Development Summit
2nd Covalent Drug Discovery and Development Summit
10
Dec
2024
Free
Conferences
Personalized Cancer Vaccine Summit
Personalized Cancer Vaccine Summit
03
Dec
2024
Free
Conferences
Cell and Gene Therapy Medical Affairs Summit
Cell and Gene Therapy Medical Affairs Summit
03
Dec
2024
Free
Conferences
Patient Recruitment for Rare Disease Trials Summit 2024
Patient Recruitment for Rare Disease Trials Summit 2024
10
Dec
2024
Free
Conferences
GPCRs-Targeted Drug Discovery Summit Europe
GPCRs-Targeted Drug Discovery Summit Europe
26
Nov
2024

GPCRs-Targeted Drug Discovery Summit Europe

Greater London, United Kingdom
Free
Conferences
7th RNA-Targeted Drug Discovery and Development Summit
7th RNA-Targeted Drug Discovery and Development Summit
10
Dec
2024
Free
Conferences

Similar Events

Bids & Proposal Strategy Conference
Bids & Proposal Strategy Conference
14
Feb
2023
International Conference on Innovative Research in Engineering and Technology
International Conference on Innovative Research in Engineering and Technology
12
Nov
2023
International Conference on Contemporary Computing
International Conference on Contemporary Computing
04
Aug
2023
Free
Conferences
International Conference on Smart Sustainable Materials and Technologies
International Conference on Smart Sustainable Materials and Technologies
12
Aug
2022
Future of Technology Summit
Future of Technology Summit
20
Nov
2023

Future of Technology Summit

London, United Kingdom
Free
Conferences
Benefits of Signin
  • Publish Your Event for Free
  • Find Upcoming Events Near By
  • Grow Your B2B Network
  • Fix B2B Meeting Online/Event
  • Showcase Products to Right People